Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Ina Schwope
Introduction
Ina Schwope is a prominent inventor based in Berlin, Germany. She has made significant strides in the field of medical research, particularly in the prognosis of breast cancer. Her work focuses on the detection of genomic sequences and the methylation state of DNA, which are crucial for predicting disease outcomes.
Latest Patents
Ina Schwope holds a patent titled "Methods for the prognosis of breast cancer." This invention relates to modified and genomic sequences, oligonucleotides, and PNA-oligomers that are used to detect the cytosine methylation state of genomic DNA. The method she developed aims to predict disease-free survival and the response of patients with cell proliferative disorders of breast tissues to endocrine treatment. She has 1 patent to her name.
Career Highlights
Ina Schwope is associated with Epigenomics AG, a company that specializes in the development of innovative cancer diagnostics. Her role at the company has allowed her to contribute to groundbreaking research that has the potential to improve patient outcomes in breast cancer treatment.
Collaborations
Throughout her career, Ina has collaborated with notable professionals in her field, including John Foekens and Nadia Harbeck. These collaborations have further enhanced her research and the impact of her inventions.
Conclusion
Ina Schwope's contributions to breast cancer prognosis through her innovative patent demonstrate her commitment to advancing medical science. Her work continues to inspire and pave the way for future research in cancer diagnostics.